Immuneering IMRX Cash Flow Statement (2020-2026)

NASDAQ IMRX
$3.73 +0.07 (+1.91%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Immuneering Quarterly Cash Flow Statement

Periods 25 quarters
Latest Jun 2026

Immuneering reported cash from operations of -$16.50M and free cash flow of -$16.53M for the quarter ended Jun 2026, down 74.7% year over year. This cash flow statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-8.53M-10.78M-12.90M-11.53M-12.84M-13.25M-13.60M-12.19M-12.60M-15.08M-14.31M-14.08M-14.60M-18.05M-15.05M-14.43M-14.96M-11.58M-13.46M-17.27M
Depreciation and DepletionDep. & Depletion
0.01M0.01M0.05M0.05M0.07M0.08M0.08M0.08M0.08M0.09M0.09M0.09M0.09M0.09M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Depreciation & Amortization (CF)Dep. & Amort.
0.01M0.01M0.05M0.05M0.07M0.08M0.08M0.08M0.08M0.09M0.09M0.09M0.09M0.09M0.09M0.08M0.08M0.08M0.08M0.08M
Share-based CompensationStock Comp.
0.64M0.63M0.90M1.05M1.07M1.05M1.27M1.33M1.48M1.64M1.47M1.66M1.64M1.72M1.69M1.52M1.46M1.64M1.64M1.63M
Gains from Sales and DivestituresGains Divest
-0.01M-666.00-817.000.00M0.00M-0.01M0.00M
Other non-cash itemsOther Non-Cash
0.03M0.16M0.25M0.18M0.03M0.06M0.11M0.11M0.11M0.09M0.09M0.08M0.08M0.08M0.08M0.09M0.09M0.09M0.09M0.09M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.02M-0.25M0.03M-0.10M-0.11M-0.06M-0.01M0.00M
Change in Account PayablesChange Payables
0.36M-0.45M0.25M-0.40M1.10M0.82M-0.43M-0.07M-0.78M0.17M0.12M0.39M-0.68M0.06M-0.69M1.19M-0.97M0.07M-0.09M1.92M
Change in Accured ExpensesChange Accured Exp.
0.07M0.55M-2.24M0.51M2.11M0.09M-2.09M0.02M0.85M1.95M-2.76M1.35M0.84M0.38M-1.61M1.15M2.37M0.99M-4.78M1.03M
Change in Other Operating AssetsOther Assets Change
1.62M-0.71M-1.42M-0.62M2.23M0.45M-0.51M-0.17M0.82M0.33M-0.28M1.01M0.71M-1.16M-1.65M-0.88M-0.18M1.10M1.18M3.49M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.02M-0.02M0.01M-0.04M-0.04M-0.03M-0.09M-0.10M-0.05M0.10M-0.32M0.00M-0.10M0.10M-0.26M0.07M-0.21M0.12M-0.34M0.07M
Other Working Capital ChangesOther WC Changes
-1.64M0.69M1.43M0.58M-2.27M-0.49M0.42M0.08M-0.87M-0.23M-0.04M-1.01M-0.81M1.25M1.39M0.95M-0.03M-0.98M-1.52M-3.42M
Cash from OperationsCash from Ops.
-9.03M-9.24M-12.28M-9.45M-10.62M-11.75M-14.42M-10.75M-12.03M-11.78M-15.49M-11.53M-13.47M-14.51M-14.08M-9.45M-11.98M-9.84M-18.43M-16.50M
Investing Activities
Capital ExpendituresCapex
0.01M0.01M0.12M0.16M0.39M0.07M0.03M0.09M0.06M0.17M0.04M0.03M0.01M0.01M0.01M0.00M0.01M0.12M0.08M0.03M
Change in Property, Plant and EquipmentChange in PP&E
-0.01M-0.01M-0.12M-0.16M-0.39M-0.07M-0.03M-0.09M-0.06M-0.17M-0.04M-0.03M-0.01M-0.01M-0.01M0.00M-0.01M-0.12M-0.08M-0.03M
Purchase of InvestmentsInvestments Purchased
22.87M7.98M10.01M19.74M12.38M28.91M15.75M88.60M71.99M11.99M
Sale and Maturity of InvestmentsInvestments Sold
20.50M32.33M19.25M20.60M19.00M9.25M5.00M19.05M21.43M5.00M5.50M9.00M22.50M
Cash from Investing ActivitiesCash from Investing
-52.77M-22.81M12.40M22.15M-0.88M8.15M18.97M9.16M-23.97M3.13M21.39M4.97M-5.42M5.49M-0.01M0.00M-0.01M-88.72M-63.07M10.48M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
120.61M0.01M0.19M0.03M0.04M0.04M0.24M28.38M-28.18M0.01M0.98M0.13M0.13M0.00M25.42M-24.77M0.18M0.02M
Net Shares Issued and RepurchasedNet Shares Issued
120.61M0.01M0.19M0.03M0.04M0.04M0.24M28.38M-28.18M0.01M0.98M0.13M0.13M0.00M25.42M-24.77M0.18M0.02M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
120.61M0.01M0.19M0.03M0.04M0.04M0.24M28.38M-28.18M0.01M0.98M0.13M0.13M0.00M25.42M-24.77M0.18M0.02M
Other financing activitiesOther financing
-0.05M-0.23M-0.04M-3.07M-0.59M
Cash from Financing ActivitiesCash from Financing
118.49M0.01M0.19M0.03M-0.02M-0.18M0.24M28.17M0.02M0.01M0.98M4.36M-0.04M13.81M-0.06M213.19M-0.36M0.18M0.02M
Additional items
Change in Cash
56.68M-32.04M0.32M12.73M-11.52M-3.78M4.79M26.59M-35.98M-8.63M6.88M-6.56M-14.52M-9.06M-0.28M-9.51M201.21M-98.92M-81.32M-6.00M
Ending Cash Balance
106.93M74.89M75.21M87.94M76.42M72.64M77.43M104.02M68.04M59.41M66.29M59.73M45.21M36.14M35.87M26.36M227.56M128.65M47.32M41.32M
Free Cash FlowFCF
-9.05M-9.25M-12.40M-9.61M-11.02M-11.82M-14.45M-10.84M-12.08M-11.95M-15.53M-11.56M-13.48M-14.52M-14.09M-9.45M-11.98M-9.96M-18.51M-16.53M
Net Cash FlowNCF
56.68M-32.04M0.32M12.73M-11.52M-3.78M4.79M26.59M-35.98M-8.63M6.88M-6.56M-14.52M-9.06M-0.28M-9.51M201.21M-98.92M-81.32M-6.00M

Immuneering Cash Flow Statement API

Pull Immuneering's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IMRX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY